Shares of Teva Pharmaceutical Industries Ltd. (TEVA) have gained 2.9% over the past four weeks to close the last trading session at $18.25, but there could still be a solid upside left in the ...
On Oct 24, the Immigration and Checkpoints Authority (ICA) said that since Sept 30, it has fully implemented passport-less clearance across all four terminals at Changi Airport. Singapore ...
About a year after the Wu administration implemented a plan that cleared a major tent encampment near the area known as Mass. and Cass, some Boston residents and officials are saying that one ...
In the latest quarter, 4 analysts provided ratings for Teva Pharmaceutical Indus (NYSE:TEVA), showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their ...
Teva gets a buy rating as it trades well below 10-year highs and shows growth potential as the leading global generic drugmaker. Their drug pipeline is robust and diverse, as well as existing ...
Barclays raised the firm’s price target on Teva (TEVA) to $25 from $22 and keeps an Overweight rating on the shares. The firm introduced Olanzapine into its model, noting TEV-749’s sales ...
Teva Pharmaceutical Industries (NYSE:TEVA) and Alvotech (NASDAQ:ALVO) said the FDA has expanded labeling for its biosimilar of Johnson & Johnson’s (JNJ) Stelara to include the treatment of Crohn ...
Todd Plummer is a travel and style writer from Boston with over ten years of experience. He has visited seven continents and over seventy countries on assignment.